Within Reach

Cancer mortality is falling across the U.S., but for too many patients in rural communities, the gap is widening - not just metaphorically, but physically, too. Barriers include hours-long drives for chemotherapy, resource limitations in hospitals, and the challenges of navigating cancer while also facing food insecurity and broadband deserts. In this episode of Within Reach , rural oncologist Dr....

When we talk about precision oncology, we usually talk about breakthroughs. But behind every advancement in targeted therapies and genomic profiling lies a quieter reality: Most patients in the world still can’t reliably access the tests that unlock these headline treatments.  This week on Within Reach, Clare Jones and Andrea Stevens expose the real bottlenecks - cost and reimbursement, fragmented...

The pace of treatment innovation in oncology is nothing short of breakneck. But the downsides of innovation are real: HCP burnout, decision fatigue, workforce attrition, and more. How can healthcare providers realistically keep up? Evan sits down with Amy Pierre from Flatiron Health, and Jahda Hill from Avalere Health, to work through the issues of innovation and information—told against the backd...

Why do people of color experience worse outcomes in cancer? How can they be better represented in clinical trials? Evan sits down with Ricki Fairley of TOUCH, The Black Breast Cancer Alliance, and Nirzari Parikh from Avalere Health, to work through the issues of health literacy, trial design, patient “fear of the sugar pill,” increasing patient self-advocacy, and more—told against the backdrop of...

If you distil the fundamental idea of health care down to its purest, most unadulterated form, the essence of it just seems so simple. When someone is sick, they should get the care that they need. But there's a heartbreaking reality to healthcare, and cancer in particular. The messy and upsetting truth is that the number of people who can get the best care — if we can even agree on what that...